TEVA

Recent Articles

How To Profit From The Next Wave Of Dividends

In this low interest rate environment, dividends are still looking great, and here are over 50 companies going ex-dividend over the next week to review More 

OPKO Health’s Healthy Buyout Binge

This healthcare name is rapidly building up a business worth watching. And the possibility of OPKO itself getting bought out isn't too remote. More 

9 Pharmaceutical Stocks to Sell Now

This week, the overall grades of nine Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

12 Intraday Movers and Shakers

Don't miss the 3%-7% moves on these momentum stocks before market close today More 

Biotech Movers: A Tough Week All Around

Amarin Corp. slides on dashed buyout hopes, while Sarepta, Galena and others also faced serious setbacks. More 

Bayer to Buy Schiff Nutrition for $1.1B

Shares of vitamin maker Schiff Nutrition (SHF) soared Wednesday on news of a buyout by pharmaceutical giant Bayer AG. More 

FDA Pulls Approval for a Generic Antidepressant

A generic version of antidepressant Wellbutrin has lost FDA approval after tests showed it less effective than the brand name drug at a certain dosage. More